DSGN Valuation

Design Therapeutics Inc (DSGN) has a current Price-to-Book (P/B) ratio of 2.70. Compared to its 3-year average P/B ratio of 1.06 , the current P/B ratio is approximately 153.34% higher. Relative to its 5-year average P/B ratio of 1.49, the current P/B ratio is about 81.47% higher. Design Therapeutics Inc (DSGN) has a Forward Free Cash Flow (FCF) yield of approximately -9.76%. Compared to its 3-year average FCF yield of -23.25%, the current FCF yield is approximately -58.04% lower. Relative to its 5-year average FCF yield of -15.86% , the current FCF yield is about -38.46% lower.